GlassScriptPhysician profile
Nicholas K Chee
NPI 1639129141
$3,113.19
in general payments reported to CMS, 2019-2025
15 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $290 · 2021: $93.82 · 2022: $469 · 2023: $789 · 2024: $710 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $936.29 | 2019-2025 | Pressurewire, Aveir, Gallant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.86 | 2022-2023 | Jardiance |
| Heartflow, INC. | $389.07 | 2020-2025 | |
| Edwards Lifesciences Corporation | $256.17 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novo Nordisk INC | $247.97 | 2023-2024 | |
| Medtronic, INC. | $194.07 | 2022-2025 | Micra |
| Actelion Pharmaceuticals US, INC. | $124.40 | 2023 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $123.74 | 2023 | Verquvo |
| Lilly USA, LLC | $109.90 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $74.99 | 2024 | |
| Lantheus Medical Imaging, INC. | $74.12 | 2023-2024 | Definity |
| Pfizer INC. | $66.31 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $44.20 | 2025 | Eliquis |
| Boston Scientific Corporation | $13.87 | 2024 | Latitude Communicator Power Supply |
| Medtronic Vascular, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Chee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.